Business Description
Regeneron Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : BRREGNBDR005
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.63 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | 0.53 | |||||
Interest Coverage | 60.69 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 10.92 | |||||
Beneish M-Score | -2.29 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16 | |||||
3-Year EBITDA Growth Rate | 5 | |||||
3-Year EPS without NRI Growth Rate | 7.9 | |||||
3-Year FCF Growth Rate | 22.8 | |||||
3-Year Book Growth Rate | 32.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 11.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.75 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.91 | |||||
9-Day RSI | 49 | |||||
14-Day RSI | 41.93 | |||||
6-1 Month Momentum % | 35.54 | |||||
12-1 Month Momentum % | 48.34 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.44 | |||||
Quick Ratio | 4.62 | |||||
Cash Ratio | 2.8 | |||||
Days Inventory | 517.52 | |||||
Days Sales Outstanding | 147.81 | |||||
Days Payable | 114.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 1.32 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 86.16 | |||||
Operating Margin % | 30.14 | |||||
Net Margin % | 32.04 | |||||
FCF Margin % | 23.19 | |||||
ROE % | 16.61 | |||||
ROA % | 12.99 | |||||
ROIC % | 18.87 | |||||
ROC (Joel Greenblatt) % | 50.19 | |||||
ROCE % | 15.6 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 26.69 | |||||
Forward PE Ratio | 21.25 | |||||
PE Ratio without NRI | 24.29 | |||||
Shiller PE Ratio | 33.89 | |||||
Price-to-Owner-Earnings | 44.33 | |||||
PEG Ratio | 1.37 | |||||
PS Ratio | 8.55 | |||||
PB Ratio | 3.94 | |||||
Price-to-Tangible-Book | 4.1 | |||||
Price-to-Free-Cash-Flow | 36.17 | |||||
Price-to-Operating-Cash-Flow | 28.3 | |||||
EV-to-EBIT | 22.58 | |||||
EV-to-Forward-EBIT | 17.93 | |||||
EV-to-EBITDA | 20.58 | |||||
EV-to-Forward-EBITDA | 16.77 | |||||
EV-to-Revenue | 7.79 | |||||
EV-to-Forward-Revenue | 6.73 | |||||
EV-to-FCF | 32.96 | |||||
Price-to-Projected-FCF | 1.64 | |||||
Price-to-DCF (Earnings Based) | 0.87 | |||||
Price-to-DCF (FCF Based) | 1.32 | |||||
Price-to-Median-PS-Value | 1.08 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.55 | |||||
Price-to-Graham-Number | 2.1 | |||||
Price-to-Net-Current-Asset-Value | 9.92 | |||||
Price-to-Net-Cash | 57.66 | |||||
Earnings Yield (Greenblatt) % | 4.42 | |||||
FCF Yield % | 2.87 | |||||
Forward Rate of Return (Yacktman) % | 18.74 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Regeneron Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil R$) | 68,201.255 | ||
EPS (TTM) (R$) | 3.198 | ||
Beta | -0.23 | ||
Volatility % | 31.98 | ||
14-Day RSI | 41.93 | ||
14-Day ATR (R$) | 1.266606 | ||
20-Day SMA (R$) | 95.287 | ||
12-1 Month Momentum % | 48.34 | ||
52-Week Range (R$) | 62.1 - 111.72 | ||
Shares Outstanding (Mil) | 6,614.07 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Regeneron Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Regeneron Pharmaceuticals Inc Stock Events
Event | Date | Price(R$) | ||
---|---|---|---|---|
No Event Data |
Regeneron Pharmaceuticals Inc Frequently Asked Questions
What is Regeneron Pharmaceuticals Inc(BSP:REGN34)'s stock price today?
When is next earnings date of Regeneron Pharmaceuticals Inc(BSP:REGN34)?
Does Regeneron Pharmaceuticals Inc(BSP:REGN34) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |